<DOC>
	<DOCNO>NCT00002407</DOCNO>
	<brief_summary>The purpose study see safe effective give one three different triple-drug combination HIV-infected patient never treat anti-HIV drug .</brief_summary>
	<brief_title>A Study Three Drug Combination Therapies HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs</brief_title>
	<detailed_description>In open-label , strategic study patient evaluate Weeks 0 , 1 , 2 , 4 , 8 , 12 Week 48 treat one follow regimen : Stavudine ( d4T ) + Didanosine ( ddI ) + Lamivudine ( 3TC ) d4T + ddI + Indinavir d4T + ddI + Nevirapine .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : Diagnosed asymptomatic HIV infection . HIV1 RNA great 500 copies/ml . CD4+ Tcell count great 200/mm3 . Never receive antiretroviral therapy . Exclusion Criteria Coexisting Condition : Excluded : Severe nonHIVrelated disease . Patients follow prior condition exclude : History neuropathy . Prior Medication : Excluded : Investigational drug within 1 month prior study . Immunomodulatory drug within 1 month prior study . Prior Treatment : Excluded : Radiation therapy within past month . Chemotherapy within past month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1998</verification_date>
</DOC>